Welcome to our dedicated page for InnovAge Holding SEC filings (Ticker: INNV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
InnovAge Holding Corp. filings document the reporting framework for a Nasdaq-listed healthcare services company built around the Program of All-inclusive Care for the Elderly (PACE). Form 8-K reports furnish quarterly operating results, financial-condition updates, Regulation FD investor presentations, guidance-related materials, and governance events such as director appointments and executive transitions.
Proxy materials describe annual meeting matters, classified-board elections, committee governance, executive and director compensation, stockholder voting procedures, and auditor ratification. The filings also identify InnovAge common stock on the Nasdaq Global Select Market and include emerging-growth-company status, common-stock registration details, capital-structure information, and public-company reporting obligations tied to its PACE care model.
Adams Benjamin C reported acquisition or exercise transactions in this Form 4 filing.
InnovAge Holding Corp. reported that Chief Financial Officer Benjamin C. Adams received an equity award of 17,123 shares of common stock in the form of Restricted Stock Units. The RSUs vest in three equal annual installments, contingent on his continued service, resulting in 17,123 directly held reported shares.
DAMATO NICOLE reported acquisition or exercise transactions in this Form 4 filing.
InnovAge Holding Corp. reported that chief legal officer Nicole Damato received a grant of 51,369 Restricted Stock Units (RSUs) on July 22, 2026. The RSUs will be settled in shares of common stock and will vest in three equal annual installments on the anniversary of the grant date, subject to her continued service. Following this award, her reported direct holdings total 328,711 shares of common stock.
Delk Meredith reported acquisition or exercise transactions in this Form 4 filing.
InnovAge Holding Corp. granted Chief Administrative Officer Meredith Delk an equity award of 42,808 Restricted Stock Units (RSUs) on 2026-07-22. The RSUs will be settled in common stock and vest in three equal annual installments on each anniversary of the grant date, contingent on Delk’s continued service. Following this award, Delk holds 42,808 RSUs reported as common stock directly.
InnovAge Holding Corp. chief executive officer Patrick T. Blair reported a tax-withholding disposition of 14,453 shares of common stock on July 16, 2026, at $11.87 per share. The shares were withheld to cover taxes upon restricted stock unit vesting, leaving him with 672,650 directly held shares and no open-market sale.
InnovAge Holding Corp. reported that Chief Legal Officer Nicole Damato had 19,401 shares of common stock withheld on July 15, 2026 to satisfy tax obligations arising from the vesting and settlement of restricted stock units, at $11.58 per share. After this tax-withholding disposition, she directly owns 277,342 shares.
ZORETIC RICHARD C reported acquisition or exercise transactions in this Form 4 filing.
InnovAge Holding Corp. reported that director Richard C. Zoretic received a grant of 8,539 Restricted Stock Units, which will be settled in common stock. These RSUs vest in full on June 30, 2027, contingent on his continued service. After this award, he directly holds 102,349 shares, reflecting routine equity-based compensation rather than an open-market trade.
TAVENNER MARILYN B reported acquisition or exercise transactions in this Form 4 filing.
InnovAge Holding Corp. director Marilyn B. Tavenner received an equity award in the form of 8,539 Restricted Stock Units, which cost her nothing per unit. These RSUs will settle in common shares and vest in full on June 30, 2027, if she continues serving the company. After this grant, she directly holds 53,696 shares.
InnovAge Holding Corp. director Teresa Sparks received an equity award in the form of restricted stock units. She acquired 8,539 RSUs that will be settled in shares of common stock and vest in full on June 30, 2027, subject to her continued service with the company. After this grant, she holds 67,665 shares of common stock directly, showing this is a routine compensation-related award rather than an open-market stock purchase or sale.
Kennedy Edward Moore Jr. reported acquisition or exercise transactions in this Form 4 filing.
InnovAge Holding Corp. director receives equity award
Director Edward Moore Kennedy Jr. was granted 8,539 Restricted Stock Units (RSUs) of InnovAge Holding Corp. common stock. These RSUs were awarded at no cash cost to him and increase his direct holdings to 76,696 shares.
The RSUs will be settled in shares of common stock and are scheduled to vest in full on June 30, 2027, as long as he continues to serve with the company. This filing reflects a compensation-related equity grant rather than an open-market stock purchase or sale.
Bush John Ellis reported acquisition or exercise transactions in this Form 4 filing.
InnovAge Holding Corp. director John Ellis Bush received an equity award of 8,539 Restricted Stock Units (RSUs), which will be settled in common shares. The RSUs vest in full on June 30, 2027, subject to his continued service. Following this grant, he directly holds 53,696 shares reported on this Form 4. This is a compensation-related award at no cash purchase price, not an open-market stock buy.